Acute effect of endothelin-1 on lung oedema induced by alpha-naphthylthiourea (ANTU)

Pharmacological Research

Volumn 33, Issue 6, 1996, Pages 375-378

  Sipahi, Emine ^a   Hodog̃lugil, Ug̃ur ^a   Ercan, Z Sevim ^a   Türker, R Kazim ^b  

^a Department of Anatomy Faculty OfMedicine AfyonKocatepeUniversity   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Alpha naphthylthiourea; Angiotensin II; Bosentan; Endothelin 1; Lung oedema; Phosphoramidon; Pleural effusion

Indexed keywords

ANGIOTENSIN; ANTIINFLAMMATORY AGENT; ANTU; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; PHOSPHORAMIDON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; LUNG EDEMA; LUNG WEIGHT; MALE; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL; RAT;

EID: 0030175194     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0052     Document Type: Article

References (26)

1. 1. Richter CP. The physiology and cytology of pulmonary edema and pleural effusion produced in rats by alphanaphthylthiourea (ANTU). J Thoracic Surg 1952; 23: 66-90.
2. 2. Cunninham AL, Hurley JV. Alphanaphthylthiourea induced pulmonary oedema in rat: A topographical and electron microscopic study. J Pathol 1972; 106: 25-35.
3. 3. Katori M, Ikeda M, Harada Y, Uchida Y, Tanaka K, Ohishi S. A possible role of prostaglandins and bradykinin as a trigger of exudation in carrageenin-induced rat pleurisy. Agents Actions 1978; 8: 108-12.
4. 4. Havill AM, Gee MH. Resolution of increased permeability pulmonary edema in rats. Am J Pathol 1987; 127: 441-6.
5. 5. Pankhania JJ, Bakhle YS. Effect of pulmonary oedema by alphanaphtyl thiourea on synthesis of cyclooxygenase products in isolated rat lungs. Prostaglandins 1982; 30: 37-49.
6. 6. Ercan ZS, Eren S, Zengil H, Türker RK. Possible involvement of eicosanoids in alpha-naphthylthiourea-induced pulmonary oedema and alteration of angiotensin-converting enzyme activity. Pharmacology 1993; 46: 274-80.
7. 7. Hardwick SJ, Skamarauskas JT, Smith LL, Upshall DG, Cohen GM. Protection of rats against the effects of α-naphthylthiourea (ANTU) by elevation of non-protein sulphydryl levels. Biochem Pharmacol 1991; 42: 1203-8.
8. 8. Lee LL, Arnau T, Neal RA. Metabolism of α-naphthylthiourea by rat liver and rat lung microsomes. Toxicol Appl Pharmacol 1980; 53: 164-73.
9. 9. Hay DWP, Henry PJ, Goldie RG. Endothelin and the respiratory system. TIPS 1993; 14: 29-32.
10. 10. Anggard E, Galton S, Rae G, Thomas R, McLoughlin L, De Nucci G, Vane JR. The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol 1989; 13 (Suppl 5): S46-9.
11. 11. Power RF, Wharton J, Zhao Y, Bloom SR, Polak JM. Autoradiographic localization of endothelin-1 binding sites in the cardiovascular and respiratory systems. J Cardiovasc Pharmacol 1989; 13 (Suppl 5): S50-6.
12. 12. Grantham CJ, Bakhle YS. Effect acute lung injury on metabolism of adenine nucleotides in rat perfused lung. Br J Pharmacol 1988; 94: 1029-36.
13. 13. Ikegawa R, Matsumura Y, Tsukahara M, Takaoka M, Morimoto S. Phosphoramidon a metalloproteinase inhibitor suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting big endothelin-1 converting enzyme. Biochem Biophys Res Commun 1990; 171: 669-75.
14. 14. Clozel M, Breu V, Gray AG, Kalina B, Löffler B-M, Burri K, Cassal J-M, Hirth G, Müller M, Neidhart W, Ramuz H. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994; 270: 228-35.
15. 15. Miller RC, Pelton JT, Huggins JP. Endothelins - from receptors to medicine. TIPS 1993; 14: 54-61.
16. 16. Naruse M, Naruse K, Kurimoto F, Horiuchi J, Tsuchiya K, Kawana M, Kato Y, Zeng Z-P, Sakurai H, Demura H, Shizume K. Radioimmunoassay for endothelin and immunoreactive endothelin in culture medium of bovine endothelial cells. Biochem Biophys Res Commun 1989; 160: 662-8.
17. 17. Germain M, Battistini B, Filep JG, Sirois P, Fournier A. Endothelin derivatives showing potent effects in the guinea-pig trachea. Peptides 1993; 14: 613-9.
18. 18. Lippton HL, Hauth TA, Summer WR, Hyman AL. Endothelin produces pulmonary vasoconstriction and systemic vasodilation. J Appl Physiol 1989; 66: 1008-12.
19. 19. Lippton HL, Ohlstein EH, Summer WR, Hyman AL. Analysis of responses to endothelin in the rabbit pulmonary and systemic beds. J Appl Physiol 1991; 70: 331-41.
20. 20. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Int Med 1991; 114: 464-9.
21. 21. Langleben D, Demarchie M, Laporta D, Spanier AH, Schlesinger RD, Stewart DJ. Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Res Dis 1993; 148: 1646-50.
22. 22. Brain SD, Tippins JR, Williams TJ. Endothelin induces potent microvascular constriction. Br J Pharmacol 1988; 95: 1005-7.
23. 23. Chander CL, Moore AR, Desa FM, Dowat DW, Willoughry DA. Antiinflammatory effects of endothelin-1. J Cardiovasc Pharmacol 1989; 13 (Suppl. 5): S218-9.
24. 24. Filep JG, Battistini B, Sirois P. Endothelin induces thromboxane release and contraction of isolated airways. Life Sci 1990; 47: 1845-50.
25. 2. Eur J Pharmacol 1992; 214: 119-25.
26. 26. Ercan ZS, Kilinç M, Yazar Ö, Korkusuz P, Türker RK. Endothelin-1-induced oedema in rat and guinea-pig isolated perfused lungs. Arch Int Pharmacodyn 1993; 323: 74-84.